Cardiovascular Disease


Vermillion, Inc.

in
Vermillion, Inc. announced the appointment of John F. Hamilton to its board of directors.

ev3 Inc

in
ev3 Inc appointed Robert J. Palmisano as President, Chief Executive Officer and Director, effective immediately. Dan Levangie, a current ev3 director and the Lead Independent Director, has been appointed non-executive Chairman of the Board of Directors.

MedCath Corp

in
MedCath Corp. announced that Pamela G. Bailey and Edward R. Casas have been appointed to its Board of Directors. Ms.

Pluristem Therapeutics Inc.

in
Pluristem Therapeutics Inc. announced that the results from Fraunhofer Institute's additional pre-clinical study utilizing the Company's proprietary PLacental eXpanded (PLX) cells in treating ischemic stroke showed statistical significance utilizing functional as well as anatomical endpoints.

CV Therapeutics, Inc. and Astellas Pharma US Inc.

in

ATS Medical Inc.

in
ATS Medical Inc. announced the first North American commercial implant of the ATS 3f(R) Aortic Bioprosthesis. Canadian regulatory approval was received at the end of December, 2007.

Vascular Solutions Inc.

in
# 1 Vascular Solutions Inc. announced that it has entered into a settlement agreement with Diomed Holdings Inc. for the purpose of resolving the patent infringement lawsuit between the companies.

St. Jude Medical Inc. signed a definitive agreement to acquire EP Medsystems Inc.

in
St. Jude Medical Inc. signed a definitive agreement to acquire EP Medsystems Inc. for $91.22 million on April 8, 2008.

Fresenius SE is in talks to acquire Sorin's Renal Care unit...

in
Fresenius SE is in talks to acquire Sorin's Renal Care unit, Financial Times Deutschland reported, citing no sources. The paper added that Fresenius is consulted by investment bank Societe Generale in the talks, while Sorin is advised by Goldman Sachs Group Inc.

ISIS Pharmaceuticals Inc.

in
 
ISIS Pharmaceuticals Inc. announced that Bristol-Myers Squibb Company has selected a compound from the companies' collaboration as a development candidate. As a result,Isis will receive a $2 million milestone payment.

123456789…next ›last »
Syndicate content